Cargando…

Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping

The bromodomain and extra-terminal (BET) bromodomains, particularly BRD4, have been identified as promising therapeutic targets in the treatment of many human disorders such as cancer, inflammation, obesity, and cardiovascular disease. Recently, the discovery of novel BRD4 inhibitors has garnered su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhimin, Gu, Lili, Wang, Beibei, Huang, Wenhai, Zhang, Yanmin, Ma, Zhen, Zeng, Shenxin, Shen, Zhengrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427567/ https://www.ncbi.nlm.nih.gov/pubmed/30879350 http://dx.doi.org/10.1080/14756366.2019.1587417

Ejemplares similares

Photopharmacology of Proteolysis-Targeting Chimeras: A New Frontier for Drug Discovery
por: Zeng, Shenxin, et al.
Publicado: (2021)

Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1)
por: Zhang, Zhimin, et al.
Publicado: (2020)

Design, Synthesis, and Bioactivity of Novel Bifunctional Small Molecules for Alzheimer’s disease
por: Liang, Meihao, et al.
Publicado: (2022)

The progress of molecules and strategies for the treatment of HBV infection
por: Pan, Youlu, et al.
Publicado: (2023)

Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitors
por: Atkinson, Benjamin N., et al.
Publicado: (2020)

On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
por: White, Tina R., et al.
Publicado: (2011)

New Lead Discovery of Herbicide Safener for Metolachlor Based on a Scaffold-Hopping Strategy
por: Deng, Xile, et al.
Publicado: (2020)

In Silico Discovery of Novel Potent Antioxidants on the Basis of Pulvinic Acid and Coumarine Derivatives and Their Experimental Evaluation
por: Martinčič, Rok, et al.
Publicado: (2015)

Antioxidants in Hops: Bioavailability, Health Effects and Perspectives for New Products
por: Zugravu, Corina-Aurelia, et al.
Publicado: (2022)

A Novel Scalarized Scaffold Hopping Algorithm with Graph-Based Variational Autoencoder for Discovery of JAK1 Inhibitors
por: Yu, Yang, et al.
Publicado: (2021)

Free energy perturbation (FEP)-guided scaffold hopping
por: Wu, Deyan, et al.
Publicado: (2022)

In silico work flow for scaffold hopping in Leishmania
por: Waugh, Barnali, et al.
Publicado: (2014)

Study of Coumarin-Resveratrol Hybrids as Potent Antioxidant Compounds
por: Matos, Maria J., et al.
Publicado: (2015)

Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design
por: Magalhães, Joana, et al.
Publicado: (2018)

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
por: Yin, Mingzhu, et al.
Publicado: (2020)

Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives
por: Niinivehmas, Sanna, et al.
Publicado: (2018)

Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X(L) Inhibitor
por: Wang, Le, et al.
Publicado: (2020)

Deep scaffold hopping with multimodal transformer neural networks
por: Zheng, Shuangjia, et al.
Publicado: (2021)

Dose-Effect Determination of a Neuroprotector Fraction Standardized in Coumarins of Tagetes lucida and Bioavailability
por: Santibáñez, Anislada, et al.
Publicado: (2023)

Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor
por: Li, Jiao, et al.
Publicado: (2021)

Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant
por: de Souza, Gabriela Alves, et al.
Publicado: (2019)

Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis †
por: Floresta, Giuseppe, et al.
Publicado: (2018)

Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes
por: Eduful, Benjamin J., et al.
Publicado: (2021)

Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds
por: Stefanachi, Angela, et al.
Publicado: (2018)

A focus on the discovery of potent and selective cyclic peptide scaffolds for drug development
por: Saunders, George J., et al.
Publicado: (2022)

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation
por: Grisoni, Francesca, et al.
Publicado: (2018)

Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor
por: Lal, Shruti, et al.
Publicado: (2023)

Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
por: He, Zhangxu, et al.
Publicado: (2022)

Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops
por: Štulíková, Kateřina, et al.
Publicado: (2018)

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
por: Zhao, Jian, et al.
Publicado: (2022)

Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and Alzheimer's disease
por: Tung, Min-Che, et al.
Publicado: (2021)

Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects
por: Kim, Young Hun, et al.
Publicado: (2021)

GLTSCR1 Negatively Regulates BRD4‐Dependent Transcription Elongation and Inhibits CRC Metastasis
por: Han, Fengyan, et al.
Publicado: (2019)

Assessing Scaffold Diversity of Kinase Inhibitors Using Alternative Scaffold Concepts and Estimating the Scaffold Hopping Potential for Different Kinases
por: Dimova, Dilyana, et al.
Publicado: (2017)

A QSAR Study on the 4-Substituted Coumarins as Potent Tubulin Polymerization Inhibitors
por: Dinparast, Leila, et al.
Publicado: (2020)

Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
por: Li, Ting-Ting, et al.
Publicado: (2020)

Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen
por: Mallinger, Aurélie, et al.
Publicado: (2015)

Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury
por: Goncalves, Maria B., et al.
Publicado: (2019)

Correction: Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and Alzheimer’s disease
por: Tung, Min-Che, et al.
Publicado: (2022)

Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
por: Aziz, Marwa A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_27jumil4j12d04s9nh4j9fkctl